Xiaoming Xu

466 total citations
18 papers, 250 citations indexed

About

Xiaoming Xu is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Epidemiology. According to data from OpenAlex, Xiaoming Xu has authored 18 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 5 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Xiaoming Xu's work include Liver Disease Diagnosis and Treatment (5 papers), Birth, Development, and Health (3 papers) and Diet, Metabolism, and Disease (3 papers). Xiaoming Xu is often cited by papers focused on Liver Disease Diagnosis and Treatment (5 papers), Birth, Development, and Health (3 papers) and Diet, Metabolism, and Disease (3 papers). Xiaoming Xu collaborates with scholars based in China, United States and Chile. Xiaoming Xu's co-authors include Yunlong Xia, Ling Tao, Huishou Zhao, Yongzhen Guo, Miaomiao Fan, Tingting Qi, Congye Li, Wenjun Yan, Guangyu Hu and Fuyang Zhang and has published in prestigious journals such as PLoS ONE, Free Radical Biology and Medicine and Neuroscience.

In The Last Decade

Xiaoming Xu

15 papers receiving 248 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoming Xu China 9 98 71 49 46 35 18 250
Aude Angelini United States 10 138 1.4× 47 0.7× 40 0.8× 103 2.2× 22 0.6× 18 336
Ruxiang Xu China 11 159 1.6× 37 0.5× 27 0.6× 9 0.2× 40 1.1× 18 346
Luca D’Orsi Italy 7 113 1.2× 87 1.2× 22 0.4× 14 0.3× 61 1.7× 9 253
Anthony Sandrasagra United States 8 126 1.3× 59 0.8× 39 0.8× 28 0.6× 10 0.3× 12 325
Dushon DeVere Riley United States 5 308 3.1× 43 0.6× 21 0.4× 47 1.0× 77 2.2× 7 370
Jie-Ru Li China 7 163 1.7× 42 0.6× 56 1.1× 44 1.0× 34 1.0× 12 334
Rupal P. Soder United States 12 218 2.2× 30 0.4× 30 0.6× 59 1.3× 17 0.5× 19 401
Guorong Liu China 10 322 3.3× 54 0.8× 63 1.3× 70 1.5× 18 0.5× 19 435
Ping Yuan China 8 126 1.3× 17 0.2× 25 0.5× 19 0.4× 38 1.1× 27 289
Iwona Pelikant‐Małecka Poland 12 160 1.6× 41 0.6× 32 0.7× 18 0.4× 41 1.2× 29 325

Countries citing papers authored by Xiaoming Xu

Since Specialization
Citations

This map shows the geographic impact of Xiaoming Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoming Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoming Xu more than expected).

Fields of papers citing papers by Xiaoming Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoming Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoming Xu. The network helps show where Xiaoming Xu may publish in the future.

Co-authorship network of co-authors of Xiaoming Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoming Xu. A scholar is included among the top collaborators of Xiaoming Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoming Xu. Xiaoming Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
Xu, Xiaoming, Peng Lu, Yunlong Xia, et al.. (2024). Fibronectin type III domain containing 4 alleviates myocardial ischemia/reperfusion injury via the Nrf2-dependent antioxidant pathway. Free Radical Biology and Medicine. 224. 256–271.
3.
Xu, Xiaoming, Zhiwen Fan, Xiaoyan Ma, et al.. (2024). Different minimal alcohol consumption in male and female individuals with metabolic dysfunction‐associated fatty liver disease. Liver International. 44(3). 865–875. 3 indexed citations
4.
Yan, Wenjun, Yunlong Xia, Huishou Zhao, et al.. (2024). Stem cell-based therapy in cardiac repair after myocardial infarction: Promise, challenges, and future directions. Journal of Molecular and Cellular Cardiology. 188. 1–14. 37 indexed citations
5.
Zhang, Xiaomeng, Jingyu Deng, Congye Li, et al.. (2024). Decreased Mrpl42 expression exacerbates myocardial ischemia and reperfusion injury by inhibiting mitochondrial translation. Cellular Signalling. 125. 111482–111482.
6.
Chen, Hao, Xin Zhang, Yongzhen Wu, & Xiaoming Xu. (2024). Indole Butyric Acid Alleviated Cadmium Toxicity in Lettuce by Increasing the Polysaccharide Contents and the Cadmium-Binding Capacity of Root Cell Walls. Journal of soil science and plant nutrition. 24(3). 5195–5207. 2 indexed citations
7.
Ma, Xiaoyan, Yee Hui Yeo, Zhiwen Fan, et al.. (2024). The impact of an increased Fibrosis-4 index and the severity of hepatic steatosis on mortality in individuals living with diabetes. Hepatology International. 18(3). 952–963. 3 indexed citations
8.
Liu, Chuan, Xiaoming Xu, Xiaoyan Ma, et al.. (2023). Association of Diabetes Mellitus with All-Cause and Cause-Specific Mortality among Patients with Metabolic-Dysfunction-Associated Fatty Liver Disease: A Longitudinal Cohort Study. Journal of Personalized Medicine. 13(3). 554–554. 1 indexed citations
9.
Qi, Tingting, Xiaoming Xu, Yongzhen Guo, et al.. (2023). CSF2RB overexpression promotes the protective effects of mesenchymal stromal cells against ischemic heart injury. Theranostics. 13(6). 1759–1773. 9 indexed citations
10.
Yeo, Yee Hui, et al.. (2023). Alcohol Intake Thresholds Among Individuals With Steatotic Liver Disease. JAMA Network Open. 6(12). e2347548–e2347548. 8 indexed citations
11.
Yan, Wenjun, Youhu Chen, Yongzhen Guo, et al.. (2022). Irisin Promotes Cardiac Homing of Intravenously Delivered MSCs and Protects against Ischemic Heart Injury. Advanced Science. 9(7). e2103697–e2103697. 40 indexed citations
12.
Xia, Yunlong, Xinyue Xu, Yongzhen Guo, et al.. (2022). Mesenchymal Stromal Cells Overexpressing Farnesoid X Receptor Exert Cardioprotective Effects Against Acute Ischemic Heart Injury by Binding Endogenous Bile Acids. Advanced Science. 9(24). e2200431–e2200431. 23 indexed citations
13.
Chen, Haiying, Hongping Zhang, Han Xie, et al.. (2021). Maternal, umbilical arterial metabolic levels and placental Nrf2/CBR1 expression in pregnancies with and without 25-hydroxyvitamin D deficiency. Gynecological Endocrinology. 37(9). 807–813. 3 indexed citations
14.
Chen, Lin, Yongzhen Guo, Yunlong Xia, et al.. (2021). FNDC5/Irisin attenuates diabetic cardiomyopathy in a type 2 diabetes mouse model by activation of integrin αV/β5-AKT signaling and reduction of oxidative/nitrosative stress. Journal of Molecular and Cellular Cardiology. 160. 27–41. 69 indexed citations
15.
Liu, Xiaohui, Zhenzhen Zheng, Hongping Zhang, et al.. (2020). Maternal 25-Hydroxyvitamin D Deficiency Promoted Metabolic Syndrome and Downregulated Nrf2/CBR1 Pathway in Offspring. Frontiers in Pharmacology. 11. 97–97. 11 indexed citations
16.
Liu, Xin, Yang Shen, Jinyan Xie, et al.. (2017). A mutation in the CACNA1C gene leads to early repolarization syndrome with incomplete penetrance: A Chinese family study. PLoS ONE. 12(5). e0177532–e0177532. 15 indexed citations
17.
18.
Yang, Rui, et al.. (2010). Sleep deprivation impairs spatial learning and modifies the hippocampal theta rhythm in rats. Neuroscience. 173. 116–123. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026